|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Physiology and Biophysics, Case Western Reserve University, School of Medicine, Cleveland, Ohio (A.W., K.Y., K.F., K.D., S.L., K.W.C.); Weis Center for Research, Geisinger Clinic, Danville, Pennsylvania (C.W., A.M.S., U.M., T.M.); and Institut de Biologie Structurale, Grenoble, France (C.M., J.R., M.V.).
Received for publication May 1, 2008.
Accepted for publication August 21, 2008.
| Abstract |
|---|
|
|
|---|
26 (last 26 residues are deleted) to examine the coassembly of different SUR. When T1 or T2 was expressed in Xenopus laevis oocytes, small whole-cell currents were activated by metabolic inhibition (induced by azide) plus a KCO (diazoxide for T1, pinacidil for T2). When coexpressed with any SUR subtype, the activated-currents were increased by 2- to 13-fold, indicating that different SUR can coassemble. Consistent with this, heteromeric SUR1+SUR2A channels were sensitive to azide, diazoxide, and pinacidil, and their single-channel burst duration was 2-fold longer than that of the T1 channels. Furthermore, SUR2A was coprecipitated with SUR1. Using whole-cell recording and immunostaining, heteromeric channels could also be detected when T1 and SUR2A were coexpressed in mammalian cells. Finally, the response of the SUR1+SUR2A channels to azide was found to be intermediate to those of the homomeric channels. Therefore, different SUR subtypes can coassemble into KATP channels with distinct metabolic sensitivities and pharmacological profiles.
KATP channels comprise two subunits: the pore-forming inwardly rectifying potassium (Kir6) channel subunit and the regulatory sulfonylurea receptor (SUR) subunit, an ATP-binding cassette (ABC) protein (Inagaki et al., 1995
). SUR primarily uses its unique N-terminal transmembrane domain, TMD0, to associate with Kir6 in a 4:4 stoichiometry to form the octameric KATP channel complex ([SUR]4[Kir6]4) (Clement et al., 1997
; Shyng and Nichols, 1997
; Babenko and Bryan, 2003
; Chan et al., 2003
). In mammals, there are two Kir6 and two SUR genes (Kir6.1 and Kir6.2; SUR1 and SUR2) (Aguilar-Bryan and Bryan, 1999
; Shi et al., 2005
). SUR2 has two major splice variants, 2A and 2B, which differ only in the C-terminal 42 amino acids. It is believed that different Kir6 combine with different SUR to form the various native KATP channels. For example, the KATP channels found in the pancreas, striated muscle, and smooth muscle are made up of SUR1+Kir6.2, SUR2A+Kir6.2, and SUR2B+ Kir6.1/Kir6.2, respectively. SUR affects the responses of KATP channels to ATP and MgADP and is crucial in determining their metabolic sensitivities. The sensitivities to energy depletion of different KATP channels follow this order: SUR1+Kir6.2
SUR2B+Kir6.2 > SUR2A+Kir6.2 (Liss et al., 1999
; Schwappach et al., 2000
; Dabrowski et al., 2003
; Masia et al., 2005
). SUR also serves as the main binding site for two important classes of drugs that target KATP channels: the sulfonylurea and potassium channel opener (Gribble and Reimann, 2002
; Moreau et al., 2005
). Different KATP channels exhibit different pharmacological profiles dictated by the SUR subtypes they are composed of.
SUR1 is generally believed to be unable to coassemble with SUR2 to form KATP channels (Giblin et al., 2002
; Babenko, 2005
; Tricarico et al., 2006
), even though SUR1 and SUR2 share
65% identity and are coexpressed in many cell types (Baron et al., 1999
; Liss et al., 1999
; Shi et al., 2005
; Tricarico et al., 2006
). We have recently demonstrated that a model in which SUR1 and SUR2A do not coassemble is incompatible with the properties of the macroscopic currents recorded from Xenopus laevis oocytes expressing SUR1, SUR2A, and Kir6.2 (Chan et al., 2008
). Furthermore, by coexpressing SUR1-Kir6.2 and SUR2A-Kir6.2(N160D) tandem dimers and studying the rectification properties of the resulting macroscopic currents, we found that SUR1 and SUR2A could coassemble, in a random manner, to form heteromeric KATP channels. Here, we report our further study on the coassembly of different SUR subtypes and explore the resulting functional consequences. First, we show SUR2A and Kir6.2 were coprecipitated with SUR1 when all three proteins were coexpressed in X. laevis oocytes. Second, by using two triple tandems in which one SUR is linked to two Kir6.2
26 (the region comprising the last 26 amino acids in Kir6.2 contains an ER retention sequence and is deleted; Fig. 2A), we show that SUR1, SUR2A, and SUR2B could coassemble in all the possible pair-wise combinations. Third, we demonstrate that KATP channels comprising two different SUR subtypes displayed hybrid pharmacological properties and novel metabolic sensitivities. Last, we demonstrate that heteromeric KATP channels were also formed in mammalian cells cultured at 37°C.
|
| Materials and Methods |
|---|
|
|
|---|
26 dimeric cassette was generated by polymerase chain reaction and subcloned into pGEMHE. SUR1 was then excised using BamHI and SalI and inserted before the Kir6.2
26 dimeric cassette to produce the SUR1-Kir6.2
26-Kir6.2
26 triple tandem (T1). The peptide sequences of linker 1 (between SUR and Kir6.2
26) and linker 2 (between adjacent Kir6.2
26) in T1 are VDGRG8DI and NSRG8DI, respectively. An XbaI site was introduced after the last sense codon of SUR2A, which was then excised using XbaI and inserted before the Kir6.2
26 dimeric cassette to produce the SUR2A-Kir6.2
26-Kir6.2
26 triple tandem (T2). The peptide sequence of linker 1 in T2 is SRVRRYGRG8DI. The SUR1 in T1 has a FLAG tag at its N terminus. The GFG sequence in the selectivity filter of Kir6.2
26 was mutated to AAA in either cassette I or cassette II of the Kir6.2
26 dimeric construct. SUR1 was then inserted to generate T1(I-AAA) and T1(II-AAA). GFP was appended to the C terminus of Kir6.2 to create Kir6.2-GFP. SUR1-HA and SUR2-HA were generated by inserting an HA epitope in the last extracellular loop (between TM16 and TM17) (Zerangue et al., 1999
Oocyte Preparation, Two-Electrode Voltage Clamp, and Inside-Out Patch Clamp Recordings. X. laevis oocytes were prepared and cultured at 18°C as described and all animal procedures were in accord with the Institutional Animal Care and Use Committee (Chan et al., 2003
). Two nanograms of T1 or T2 with or without 3 ng of SUR1, SUR2A, or SUR2B were injected into oocytes for two-electrode voltage clamp (TEVC), Western blot, and immunoprecipitation. The same T1 and T1+SUR2A RNA solutions were then diluted 5 to 20 times for single-channel recording. TEVC was used to measure whole-cell currents from X. laevis oocytes using an OC-725 amplifier (Warner Instruments, Hamden, CT). Bath solution contains 96 mM KCl, 2 mM NaCl, 1 mM MgCl2, 5 mM HEPES, and 1.8 mM CaCl2, pH 7.5. 3M sodium azide (in water; Sigma, St. Louis, MO), 340 mM diazoxide (in dimethyl sulfoxide; Sigma), 200 mM pinacidil (ethanol; Sigma), 20 mM glibenclamide (dimethyl sulfoxide; Sigma), and 1 M BaCl2 (water) were used as stocks. To monitor whole-cell conductance, oocyte membrane was held at 0 mV, and 1-s ramps from -100 to +100 mV were applied at 1.5-s interval. Currents were filtered at 1 kHz and sampled at 2 kHz. Currents at -80 mV from the ramp were used to plot the time courses and for comparing current magnitudes. An Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA) was used for patch clamping in the inside-out configuration. Pipette solution contained 140 mM KCl, 1 mM MgCl2, 1 mM CaCl2, and 10 mM HEPES, pH 7.4. Bath solution contained 140 mM KCl, 1 mM EGTA, 1 mM EDTA, and 10 mM HEPES, pH 7.4. Single-channel recordings were obtained at -60 mV and the currents were filtered at 2 kHz and sampled at 25 kHz. Pipette resistances were 3 to 5 M
. Analyses of single channel records were performed as described previously, using a combination of pCLAMP 9 (Molecular Devices) and in-house programs (Fang et al., 2006
). The open-time and closed-time distributions obtained from single-channel records were best fitted by one and four exponential components, using maximum likelihood.
ci and aci are the time constant and the fractional contribution of the ith closed time component, respectively (i = 1-4).
o is the true mean open time obtained from the observed mean open time (
o,obs) after correction for the filter dead time (td
0.09 ms) [i.e.,
=
o o,obs x e-td/
c1 (Fang et al., 2006
)]. The number of channel closures within a burst (N), the burst duration (
b), and the interburst duration (
ib) were calculated as follows: N = [ac1/(ac2 + ac3 + ac4)] = [ac1/(1 - ac1)];
b = (N + 1) x
o + N x
c1;
ib = (ac2 x
c2 + ac3 x
c3)/(ac2+ ac3). All electrophysiological data were obtained at room temperature (25°C) and are given as mean ± S.E.M (n
5).
Oocyte Crude Membrane Preparation, Western Blot Analysis, and Immunoprecipitation. Oocyte crude membranes were prepared 2 to 3 days after injection, as described previously (Chan et al., 2003
). Resuspended crude membrane proteins were mixed with standard sample loading buffer at room temperature without heating and were resolved on SDS-polyacrylamide gels and transferred to nitrocellulose membranes for Western blot analyses using the anti-HA (from rat; Roche Applied Science, Indianapolis, IN), or anti-FLAG (M2, from mouse; Sigma) or anti-GFP antibodies (from mouse; Invitrogen, Carlsbad, CA). Crude membranes were solubilized in 1% digitonin (Calbiochem, San Diego, CA) or Triton X-100 (Sigma), and immunoprecipitations were performed using M2 antibodies conjugated to agarose beads (Sigma).
|
Expression and Whole-Cell Recordings in COS-7 Cells. African green monkey kidney fibroblast (COS-7) cells were cultured at 37°C in minimal essential medium supplemented with 10% FBS. T1, SUR1-HA, SUR2A-HA, and Kir6.2-HA were subcloned into pcDNA3. Cells were transfected using Lipofectamine2000 (Invitrogen) with the following amounts of DNA for different constructs, as indicated for each experiment: 2 µg of T1, 1.6 µg of SUR1-HA, 1.6 µg of SUR2A-HA, and 0.1 µg of pEGFP-N1 (Clontech, Palo Alto, CA). Patch-clamp recordings were made 36 to 72 h after transfection. Glass coverslips containing transfected cells were placed in a chamber that was constantly superfused with high potassium (HK) solution with the following composition: 140 mM KCl, 2.6 mM CaCl2, 1.2 mM MgCl2, and 5 mM HEPES, pH 7.4. Whole-cell patch-clamp recordings were performed at room temperature by using a MultiClamp700B amplifier (Molecular Devices). Pipettes were filled with 140 mM KCl, 1.2 mM MgCl2, 1 mM CaCl2, 10 mM EGTA, 5 mM HEPES, pH 7.4, supplemented with 3 mM Mg-ATP; and typical resistances were 3 to 6 M
. Cells were held at 0 mV and a 475-ms ramp from -100 to +100 mV was applied once every 0.5 or 2 s. Whole-cell capacitance was fully compensated. Currents were filtered at 1 kHz and sampled at 2 kHz. Currents at -80 mV from the ramp were used to plot the time courses and for comparing current magnitudes.
Immunocytochemistry. HEK-293 cells were plated at a density of 5 x 105 cells per plate on polylysine-treated, 35-mm glass-bottomed dishes. On the following day, the cells were transiently transfected with SUR1-HA or SUR2A-HA (0.5 µg each) with or without T1 (0.625 µg) as well as a CFP-tagged membrane marker (CFP fused to the first 20 amino acids of GAP-43; Clontech). Control cells were transfected using empty pcDNA3 vector. Transfected cells were fixed using 4% paraformaldehyde and permeabilized using 0.05% Triton X-100. The cells were stained with rat anti-HA (Roche) followed by Alexa Fluor 594-conjugated chicken anti-rat-IgG (Invitrogen). Cells were washed extensively using phosphate-buffered saline and imaged using a spinning-disk confocal microscope (Olympus, Tokyo, Japan). All images were processed using IPLab software (BD Biosciences Bioimaging, Rockville, MD).
| Results |
|---|
|
|
|---|
|
26 cassettes through glycine linkers (Fig. 2A). Using X. laevis oocytes, T1 and T2 were expressed alone or with different SUR. Whole-cell currents were recorded from oocytes using TEVC. As shown in Fig. 3A, oocytes expressing T1 exhibited a small basal current that could be further activated by sodium azide, a metabolic inhibitor that increases the amount of intracellular ADP at the expense of ATP (Gribble et al., 1997
26 (data not shown). However, the magnitude of the current at maximal activation (Itot = -3.70 ± 0.7 µA; n = 8) was much smaller compared with SUR1+Kir6.2
26 (Itot = -52 ± 6 µA; n = 11), suggesting that T1 alone is inefficient in forming functional KATP channels. It is noteworthy that the glibenclamide sensitivity of the T1 channels was less than that of the SUR1+Kir6.2
26 channels (
97% of Itot was inhibited by 10 µM glibenclamide for SUR1+Kir6.2
26; n = 5). A possible reason that T1 could be functionally expressed in oocytes is the absence of the ER retention sequence in the Kir6.2
26 subunit. Figure 2B shows some possible assembly configurations for functional channels formed by T1 alone. It is clear that all the configurations shown represent channels with either impaired stoichiometry and/or with serious steric hindrance.
Next, we coexpressed T1 and SUR1 to investigate whether they could assemble. Oocytes expressing T1+SUR1 exhibited much larger basal currents compared with those expressing T1 alone (Fig. 3B and Table 1). The basal current was robustly activated by azide and diazoxide. A switch from diazoxide to pinacidil again led to a small reduction in the current. Glibenclamide promptly inhibited
90% of the activated current and the remaining small current was blocked by Ba2+. The characteristics and the magnitude of the currents resulting from T1+SUR1 were similar to those from oocytes expressing SUR1+Kir6.2
26 (for T1+SUR1, Itot = -31.24 ± 4.64 µA; n = 8). It is noteworthy that the basal and the total currents were 6- and 8-fold larger, respectively, compared with those from oocytes expressing T1 alone (Fig. 3E and Table 1). As a control, when T1 was expressed with MRP1, another TMD0-containing ABC protein, the resulting basal and total currents were only -0.19 ± 0.17 and -1.87 ± 0.11 µA, respectively (Table 1). These data indicate that freely expressed SUR1, but not MRP1, can assemble with T1 to enhance the formation of functional channels.
|
|
26 cassettes of T1. Two mutants, T1(I-AAA) and T1(II-AAA), with the conserved GFG pore-loop sequence mutated to AAA in cassette I and II, respectively, were designed (Fig. 2A). These Kir6.2 pore mutations have a dominant-negative effect within the tetrameric KATP channel (Pountney et al., 2001
26)2]2 and therefore does not deviate from the wild-type octameric structure.
Using the Triple Tandem Construct T1 to Study the Coassembly of SUR1 and SUR2. To address whether SUR2A and SUR2B could assemble with T1 to form functional channels, T1 was coexpressed with SUR2A and SUR2B, and the basal and activated currents were measured (Fig. 3, C and D). Oocytes expressing T1+SUR2A and T1+SUR2B exhibited small basal currents that could be stimulated by azide and diazoxide. Compared with T1 alone, the basal currents for T1+SUR2A and T1+SUR2B were approximately twice as large and currents activated by azide plus diazoxide (i.e., Iaz + Idzx) were
4- and 6-fold larger, respectively (Fig. 3E and Table 1). We also found that SUR2A, when coexpressed with T1(I-AAA) or T1(II-AAA), produced no significant activated currents (<-1.4 µA; n = 10). These data indicate that T1 (i.e., SUR1) can also coassemble with SUR2A and SUR2B to generate KATP channels with SUR1 properties. The most likely stoichiometry of these coassembled channels is [SUR2]2[SUR1-(Kir6.2
26)2]2, and the two possible configurations for SUR1-SUR2 hybrid channels are shown in Fig. 2C. We tested whether these hybrid channels display SUR2-specific properties. Indeed, current from T1+SUR2A could be robustly activated by pinacidil (
60% of the total current) (Fig. 3C). As a result, the total current from T1+SUR2A was comparable with that of T1+SUR1 and was
8-fold larger than that of T1 alone (Fig. 3E and Table 1). Even in the absence of prior azide preconditioning, pinacidil could still activate T1+SUR2A channels, albeit much less effectively (data not shown). It is noteworthy that pinacidil failed to activate the current from T1+SUR2B (Fig. 3D), even though it can activate SUR2B+Kir6.2
26 (data not shown). Nevertheless, these data indicate that it is possible for SUR2A to assemble with SUR1 to generate KATP channels with both SUR1-(azide and diazoxide sensitivities) and SUR2A-specific (pinacidil activation) properties.
|
160, 280, and 500 kDa. These bands are likely to represent the monomeric, dimeric and trimeric forms of SUR1 (predicted sizes are 178, 356, and 534 kDa, respectively), with the middle band running anomalously at a size much smaller than the predicted MW of a dimer. T1 was detected as two bands running at
190 and 500 kDa that could represent its monomers and dimers (predicted sizes are 262 and 524 kDa), with the lower band running anomalously at a size smaller than that predicted for a monomer. SUR1 and SUR2A could also be detected in the blot when probed with the anti-HA antibody (Fig. 4B). For each protein, the signal appeared as a sharp band and a trailing smear. As shown before, these represent the core and mature glycosylated forms of the SUR protein, respectively (Zerangue et al., 1999
Incorporation of SUR2A into T1 Results in Longer Burst Durations. We asked whether the incorporation of SUR into T1 channels would affect the single channel properties of T1. To this end, we focused on T1 and T1+SUR2A channels for two reasons. First, it has been shown that both the intrinsic open probability (Po) and the burst duration of SUR2A+Kir6.2 are larger compared with SUR1+Kir6.2 (Babenko et al., 1999
; Fang et al., 2006
). We reasoned that SUR2A would have a larger observable effect on the single channel properties of T1 than SUR1. Second, we were most interested in whether SUR1 and SUR2A could coassemble. Figure 5A shows representative single channel recordings for T1 and T1+SUR2A channels. T1 and T1+SUR2A had identical single channel conductance (
58 pS at -60 mV; Table 2) and their open and closed times were best fitted with one and four exponential components, respectively (Fig. 5B). Their intraburst kinetics, as revealed by the fastest closed time (
c1) and the open time (
o), their mean interburst closed times (
ib), and Po, were not significantly different (at p < 0.05; Table 2). However, the mean burst duration for T1+SUR2A was
2-fold longer than that of T1 (280 ms versus 123 ms; p < 0.015). These data further indicate that SUR2A can associate with T1 to form heteromeric channels with longer burst duration.
|
|
Using the Triple Tandem Construct T2 to Study the Coassembly of Different SUR Subtypes. As shown above, T1 can be used to test whether SUR1 can assemble with SUR2A and SUR2B. However, T1 cannot be used to address whether SUR2A can assemble with SUR2B. T2 was constructed specifically for this aim (Fig. 2A). Similar to T1, T2 could form functional channels when expressed in oocytes (Fig. 6A). Basal current from T2 was small and insensitive to azide and diazoxide but could be stimulated by pinacidil. The stimulated current was sensitive to glibenclamide and Ba2+. When T2 was coexpressed with SUR1 or with SUR2A, the currents activated by pinacidil were 12- and 3-fold larger compared with that measured for T2 alone, respectively (Fig. 6 and Table 1). In addition, T2+SUR1, but not T2+SUR2A, was sensitive to azide and diazoxide (Figs. 6, B, C, and E). When T2 was coexpressed with SUR2B, the current activated by pinacidil was
2-fold larger compared with that measured for T2 alone (Fig. 6D and Table 1). Azide could not stimulate current from T2+SUR2B but diazoxide could clearly cause a small activation. These data demonstrate that T2 could assemble with SUR1, SUR2A, and SUR2B leading to an increase in the pinacidil-activated currents (Fig. 6E and Table 1). Diazoxide sensitivity was also conferred by SUR1 and SUR2B but azide stimulation was observed only in the presence of SUR1.
T1 Can Assemble with SUR1 or SUR2A to Form Functional KATP Channels in Mammalian Expression System. Our data presented so far were obtained from X. laevis oocytes cultured at 18°C. To address whether SUR1 and SUR2A could coassemble to form functional heteromeric channels in mammalian cells at 37°C, we expressed T1, T1+SUR1, and T1+SUR2A in COS-7 cells and performed whole-cell recordings. Currents from COS-7 cells expressing SUR1+Kir6.2 and SUR2A+Kir6.2 were characterized first and found to display typical subtype-specific activation by KCOs. In addition, the latter but not the former currents were reversibly inhibited by glibenclamide (data not shown). In cells expressing T1 alone or T1+SUR1 (Fig. 7, A and B), diazoxide, but not pinacidil, was able to activate the currents, which could be inhibited by glibenclamide and the remaining currents could be blocked by Ba2+. After a 5-min wash with HK solution, application of diazoxide could not reactivate the currents. Hence, T1 alone or T1+SUR1 could form functional KATP channels with properties similar to SUR1+Kir6.2. However, the mean current density of T1+SUR1 (Itot = 133 ± 22 pA/pF; n = 6) was
3-fold larger than that of T1 alone (Itot = 43 ± 7 pA/pF; n = 5) (Fig. 7, A, B, and D). These data are consistent with our findings in oocytes (Fig. 2) and reports that showed irreversible glibenclamide block of SUR1+Kir6.2 channels (Gribble et al., 1997
, 2002
). Figure 7C shows the current from a cell expressing T1+SUR2A, which could be activated by diazoxide and further activated by pinacidil. Both activated currents could be inhibited by glibenclamide. Hence T1+SUR2A can generate KATP currents in COS-7 cells with characteristics qualitatively identical to those from oocytes expressing T1+SUR2A, indicating that functional heteromeric SUR1-SUR2Achannels can also be formed in COS-7 cells. The cell shown in Fig. 7C was subsequently washed for 5 min. After washing, the currents could not be reactivated by diazoxide but were readily re-activated by pinacidil, which could be subsequently inhibited by glibenclamide (Fig. 7C). The mean current density from the second pinacidil application (29 ± 7 pA/pF; n = 6) was
65% of that from the first application (45 ± 1 pA/pF; n = 6) (Fig. 7D). Summary of the recordings from all three groups are shown in Fig. 7D.
|
Next, we examined the changes in the surface localization of SUR1 and SUR2A in HEK-293 cells when they were expressed alone and with T1 (SUR1 and SUR2A were HA-tagged). When expressed alone, SUR1 and SUR2A proteins were mostly intracellularly located (Fig. 8, A and C). In the presence of T1, both SUR1 and SUR2A were largely detected on the cell surface (Fig. 8, B and D). Cells transfected with empty vector and those where the primary antibody was left out were used as negative controls (Fig. 8, E and F). For all immunofluorescence experiments a CFP-tagged membrane marker was cotransfected and imaged to clearly identify the plasma membrane (not shown). These data suggest that heteromeric KATP channels containing both SUR1 and SUR2A are largely located in the cell membrane when expressed in HEK-293 cells.
|
) for T1+SUR1 and SUR1+Kir6.2
26 were not significantly different (308 ± 12 versus 277 ± 16 s). The t
for T1+SUR1 was smaller than that for T1+SUR2B (366 ± 12 s; p < 0.01), which was in turn smaller than that for T1+SUR2A (418 ± 14 s; p < 0.03) (Fig. 9A). The extent of azide activation was highest for T1+SUR1. At 3 mM azide, the activated current was
2- and 3-fold larger compared with that activated for T1+SUR2B and T1+SUR2A, respectively (Table 1); at a saturating concentration of 5 mM, azide stimulated T1+SUR1
5-fold more than T1+SUR2A (data not shown). Figure 9B shows the representative time courses of the normalized currents obtained from T1+SUR1 and T1+SUR2A in the sequential presence of two different doses of azide (1 mM followed by 5 mM). The ratio of the current response to 1 mM over that to 5 mM azide was 0.43 ± 0.07 (n = 5) for T1+SUR1, which was
2.5-fold higher than for T1+SUR2A (ratio = 0.16 ± 0.03; n = 5), indicating that T1+SUR1 was more sensitive to azide activation. Taken together, the rate and extent of activation by metabolic inhibition of the SUR1-SUR2 hybrid channels were intermediate, between those of SUR1 channels (large rapid activation and higher sensitivity to low dose of metabolic inhibitor) and SUR2A channels (no detectable activation).
|
| Discussion |
|---|
|
|
|---|
SUR1 Can Coassemble with SUR2A in X. laevis Oocytes and in Mammalian Cells. There were six lines of evidence indicating that SUR1 can coassemble with SUR2A in X. laevis oocytes. First, the azide plus diazoxide activated currents from the T1+SUR2A channels were
4-fold larger than those from the T1 channels (Fig. 3, A, C, and E). Likewise, the azide plus pinacidil activated currents from the T2+SUR1 channels were
13-fold larger than those from the T2 channels (Fig. 6, A, B, and E). This might be due to an increase in the number of channels expressed on the cell membrane, because the ATP sensitivities (data not shown) and the Po of the T1 and T1+SUR2A channels were similar. Second, SUR2A could associate with T1 and became maturely glycosylated (Fig. 4, B and C). This indicates that the T1-SUR2A complex can transit from the ER to the Golgi bodies and finally traffic to the cell membrane. Third, the T1+SUR2A and the T2+SUR1 channels were sensitive to pinacidil (SUR2-specific) in addition to azide and diazoxide (SUR1-specific) (Figs. 3C and 6B). Fourth, the glibenclamide sensitivities of the T1+SUR2A and T2+SUR1 channels were higher than those of the T1 and T2 channels by themselves (Table 1). This is consistent with the idea that any SUR subtype can incorporate into T1 and T2 thereby increasing their glibenclamide sensitivities. Fifth, SUR2A could increase the burst duration of T1 by 2-fold (Fig. 5 and Table 2), consistent with SUR2A assembling with and prolong the burst durations of single T1 channels (Babenko et al., 1999
; Fang et al., 2006
). Last, in the presence of Kir6.2, SUR2A could associate with SUR1 even when all three proteins were expressed separately (Fig. 2). These immunoprecipitation data are in contrast with the results presented by Giblin et al. (2002
) who concluded that SUR1 could not coprecipitate SUR2A. This discrepancy may be due to the different expression systems used (X. laevis oocytes versus HEK-293 cells) and the different antibodies employed in the immunoprecipitations (anti-FLAG versus anti-SUR antibodies). Nevertheless, the positive biochemical data we obtained are consistent with our functional data strongly supporting the notion that SUR1 and SUR2 do coassemble. It is also noteworthy that in our immunoprecipitation experiment, a positive control in which SUR1-HA was coimmunoprecipitated with F-SUR1 was included.
The pharmacological characteristic of the whole-cell currents recorded from COS-7 cells expressing T1+SUR2A was qualitatively similar to that recorded from oocytes expressing T1+SUR2A (Figs. 3C and 7C), demonstrating that heteromeric SUR1-SUR2A channels can also be formed in mammalian cells cultured at 37°C. It is noteworthy that heteromeric SUR1-SUR2A channels could be reactivated by pinacidil (but not by diazoxide) after a 5-min washout of glibenclamide (Fig. 7). The mean ratio of the second pinacidil response to the first response was less than 1 (0.65), which might be due to current run-down. These data provide novel insights into the complex interaction between different KCOs and sulfonylurea, challenging the assumption that heteromeric SUR1-SUR2A channels cannot be activated by SUR2-specific openers after a 5-min washout of the high-affinity glibenclamide (Giblin et al., 2002
). Such assumption led Giblin et al. (2002
) to interpret one of their experimental results as evidence that SUR1 and SUR2A cannot coassemble. The immunostaining data obtained from HEK-293 cells indicate that T1 can interact with SUR1 and SUR2A and chaperone them to the cell surface (Fig. 8). The strikingly similar staining patterns of SUR1 and SUR2A in the absence or the presence of T1 further suggest that the SUR1 subunit within T1 associates with a free SUR1 or SUR2A subunit in a nondiscriminate manner. Using the voltage-dependent spermine blocker, we have demonstrated that the tandem dimers SUR1-Kir6.2 (a weak rectifier) and SUR2A-Kir6.2(N160D) (a strong rectifier) coassemble to form functional KATP channels in a random manner (Chan et al., 2008
).
SUR2B Can Coassemble with SUR1 and SUR2A. SUR2B, like SUR2A, boosted the T1 channel expression: the (azide+diazoxide)-activated current from T1+SUR2B was
6.5-fold larger than that from T1. This potentiating effect of SURB on T1 was even stronger than that of SUR2A (
4-fold). Therefore, SUR2B must be able to assemble with SUR1 at least as well as SUR2A. We were surprised to find that T1+SUR2B channels were not sensitive to pinacidil, although the SUR2B+Kir6.2 channels are activated by pinacidil as well as, if not better than, the SUR2A+Kir6.2 channels (data not shown) (Shindo et al., 1998
). This suggests a difference in the way SUR2A and SUR2B interact with SUR1. SUR2A and SUR2B are 98% identical, and although it is generally believed that they can coassemble (Giblin et al., 2002
; Tricarico et al., 2006
), this interaction has not been directly demonstrated. Our data on T2+SUR2B provide clear evidence of their coassembly. First, the total current for T2+SUR2B was
2-fold larger compared with the T2 channels. Although this relative increase was modest, it was comparable with that of the T2+SUR2A channels (
3-fold). Second, unlike T2+SUR2A, the T2+SUR2B channels could be clearly activated by diazoxide, although the activation was relatively small and variable. These data are in line with the diazoxide responses of wild-type SUR2B+Kir6.2 and SUR2A+Kir6.2 channels (Matsuoka et al., 2000
).
Physiological and Pharmacological Significance of Coassembly of Different SUR Subtypes. It has been shown that the Kir6.1 and Kir6.2 are coexpressed in many tissues and they can form heteromers (Karschin et al., 1997
; Babenko et al., 2000
; Cui et al., 2001
; Thomzig et al., 2005
). However, the biological significance of this coassembly is unclear because Kir6.1 and Kir6.2 have similar ATP sensitivities (Babenko and Bryan, 2001
). On the other hand, the heteromerization of SUR has obvious implications on cellular functions, because the metabolic sensitivity, the most important physiological property of KATP channels, is largely determined by SUR (Liss et al., 1999
; Schwappach et al., 2000
; Dabrowski et al., 2003
; Masia et al., 2005
). Therefore, one possible outcome of the heteromerization of SUR is generation of KATP channels with intermediate metabolic sensitivities. Our data support this idea. Compared with the T1+SUR2A (SUR1+SUR2A) channels, the azide-response of the T1+SUR1 (SUR1) channels was faster (shorter t
of activation), stronger (at all azide concentrations), and displayed a higher apparent affinity (Fig. 9). Because the SUR2A channels are insensitive to metabolic inhibition induced by azide, the response of the SUR1+SUR2A channels to metabolic inhibition is intermediate between those of the SUR1 and SUR2A channels. We predict that the metabolic sensitivities of all the possible SUR channels should follow this rank: SUR1 > SUR1+SUR2B > SUR1+SUR2A > SUR2B > SUR2A+ SUR2B > SUR2A channels.
The heteromerization of SUR also has important implication on the pharmacology of KATP channels. Among the many blockers and openers of KATP channels, several are already in clinical use: sulfonylurea blockers are common antidiabetics, and potassium channel openers such as diazoxide and nicorandil are used to treat hypertension, pectoris angina, and persistent hyperinsulinemic hypoglycemia of infancy (Touati et al., 1998
; Darendeliler et al., 2002
; Ashcroft, 2005
; Jahangir and Terzic, 2005
). These drugs bind primarily to SUR with subtype-specific affinities, resulting in differential effects on the various types of KATP channels (Gribble and Reimann, 2002
, 2003
; Moreau et al., 2005
). In light of our finding, the composition of native KATP channels should be reconsidered in those tissues coexpressing different SUR subtypes, and the pharmacology of hybrid KATP channels should be characterized. This knowledge will be invaluable in designing new drugs targeting tissue-specific KATP channels and in guiding their administrations to minimize undesirable side effects.
| Acknowledgements |
|---|
| Footnotes |
|---|
ABBREVIATIONS: SUR, sulfonylurea receptor; ABC, ATP-binding cassette; HA, hemagglutinin; TEVC, two-electrode voltage clamp; HK, high potassium; GFP, green fluorescent protein; CFP, cyan fluorescent protein; potassium channel opener; HEK, human embryonic kidney; diazoxide, 7-chloro-3-methyl-4H-1,2,4-benzothiadiazine 1,1-dioxide; ER, endoplasmic reticulum; glibenclamide, 5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxy-benzamide; pinacidil, 3-cyano-1-(4-pyridyl)-2-(1,2,2-trimethylpropyl)guanidine; Po, open probability.
The online version of this article (available at http://molpharm.aspetjournals.org) contains supplemental material. ![]()
1 Current affiliation: Department of Pediatrics, Case Western Reserve University, School of Medicine Rainbow Babies and Children's Hospital, Cleveland, Ohio. ![]()
2 Current affiliation: Departments of Physiology and Medicine and the Cardiovascular Research Laboratories, David Geffen School of Medicine at UCLA, Los Angeles, California. ![]()
3 Current affiliation: Department of Pharmacological Sciences, CV Therapeutics, Palo Alto, California. ![]()
Address correspondence to: Kim W. Chan, Department of Pharmacological Sciences, CV Therapeutics, 1651 Page Mill Rd, Palo Alto, CA 94304. E-mail: kim.chan{at}cvt.com
| References |
|---|
|
|
|---|
Ashcroft FM (2005) ATP-sensitive potassium channelopathies: focus on insulin secretion. J Clin Invest 115: 2047-2058.[CrossRef][Medline]
Babenko AP (2005) KATP channels "vingt ans apres": ATG to PDB to mechanism. J Mol Cell Cardiol 39: 79-98.[CrossRef][Medline]
Babenko AP and Bryan J (2001) A conserved inhibitory and differential stimulatory action of nucleotides on Kir6.0/SUR complexes is essential for excitation-metabolism coupling by KATP channels. J Biol Chem 276: 49083-49092.
Babenko AP and Bryan J (2003) Sur domains that associate with and gate KATP pores define a novel gatekeeper. J Biol Chem 278: 41577-41580.
Babenko AP, Gonzalez G, and Bryan J (1999) Two regions of sulfonylurea receptor specify the spontaneous bursting and ATP inhibition of KATP channel isoforms. J Biol Chem 274: 11587-11592.
Babenko AP, Gonzalez GC, and Bryan J (2000) Hetero-concatemeric kir6.x4/SUR14 channels display distinct conductivities but uniform ATP inhibition. J Biol Chem 275: 31563-31566.
Baron A, van Bever L, Monnier D, Roatti A, and Baertschi AJ (1999) A novel KATP current in cultured neonatal rat atrial appendage cardiomyocytes. Circ Res 85: 707-715.
Chan KW, Wheeler A, and Csanády L (2008) Sulfonylurea receptors type 1 and 2A randomly assemble to form heteromeric KATP channels of mixed subunit composition. J Gen Physiol 131: 43-58.[CrossRef][Medline]
Chan KW, Zhang H, and Logothetis DE (2003) N-terminal transmembrane domain of the SUR controls trafficking and gating of Kir6 channel subunits. EMBO J 22: 3833-3843.[CrossRef][Medline]
Clement JP 4th, Kunjilwar K, Gonzalez G, Schwanstecher M, Panten U, Aguilar-Bryan L, and Bryan J (1997) Association and stoichiometry of KATP channel subunits. Neuron 18: 827-838.[CrossRef][Medline]
Cui Y, Giblin JP, Clapp LH, and Tinker A (2001) A mechanism for ATP-sensitive potassium channel diversity: functional coassembly of two pore-forming subunits. Proc Natl Acad Sci U S A 98: 729-734.
Dabrowski M, Larsen T, Ashcroft FM, Bondo Hansen J, and Wahl P (2003) Potent and selective activation of the pancreatic beta-cell type KATP channel by two novel diazoxide analogues. Diabetologia 46: 1375-1382.[CrossRef][Medline]
Darendeliler F, Fournet JC, Ba
F, Junien C, Gross MS, Bundak R, Saka N, and Günöz H (2002) ABCC8 (SUR1) and KCNJ11 (Kir6.2) Mutations in persistent hyperinsulinemic hypoglycemia of infancy and evaluation of different therapeutic measures. J Pediatr Endocrinol Metab 15: 993-1000.[Medline]
Fang K, Csanády L, and Chan KW (2006) The N-terminal transmembrane domain (TMD0) and a cytosolic linker (L0) of sulphonylurea receptor define the unique intrinsic gating of KATP channels. J Physiol 576: 379-389.
Giblin JP, Cui Y, Clapp LH, and Tinker A (2002) Assembly limits the pharmacological complexity of ATP-sensitive potassium channels. J Biol Chem 277: 13717-13723.
Gribble FM, Ashfield R, Ammälä C, and Ashcroft FM (1997) Properties of cloned ATP-sensitive K+ currents expressed in Xenopus oocytes. J Physiol 498: 87-98.
Gribble FM and Reimann F (2002) Pharmacological modulation of KATP channels. Biochem Soc Trans 30: 333-339.[CrossRef][Medline]
Gribble FM and Reimann F (2003) Sulphonylurea action revisited: the post-cloning era. Diabetologia 46: 875-891.[CrossRef][Medline]
Inagaki N, Gonoi T, Clement JP 4th, Namba N, Inazawa J, Gonzalez G, Aguilar-Bryan L, Seino S, and Bryan J (1995) Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor. Science 270: 1166-1170.
Jahangir A and Terzic A (2005) KATP channel therapeutics at the bedside. J Mol Cell Cardiol 39: 99-112.[CrossRef][Medline]
Karschin C, Ecke C, Ashcroft FM, and Karschin A (1997) Overlapping distribution of KATP channel-forming kir6.2 subunit and the sulfonylurea receptor SUR1 in rodent brain. FEBS Lett 401: 59-64.[CrossRef][Medline]
Liss B, Bruns R, and Roeper J (1999) Alternative sulfonylurea receptor expression defines metabolic sensitivity of KATP channels in dopaminergic midbrain neurons. EMBO J 18: 833-846.[CrossRef][Medline]
Masia R, Enkvetchakul D, and Nichols CG (2005) Differential nucleotide regulation of KATP channels by SUR1 and SUR2A. J Mol Cell Cardiol 39: 491-501.[CrossRef][Medline]
Matsuoka T, Matsushita K, Katayama Y, Fujita A, Inageda K, Tanemoto M, Inanobe A, Yamashita S, Matsuzawa Y, and Kurachi Y (2000) C-terminal tails of sulfonylurea receptors control ADP-induced activation and diazoxide modulation of ATP-sensitive K+ channels. Circ Res 87: 873-880.
Moreau C, Prost AL, Dérand R, and Vivaudou M (2005) SUR, ABC proteins targeted by KATP channel openers. J Mol Cell Cardiol 38: 951-963.[CrossRef][Medline]
Pountney DJ, Sun ZQ, Porter LM, Nitabach MN, Nakamura TY, Holmes D, Rosner E, Kaneko M, Manaris T, Holmes TC, et al. (2001) Is the molecular composition of KATP channels more complex than originally thought? J Mol Cell Cardiol 33: 1541-1546.[CrossRef][Medline]
Schwappach B, Zerangue N, Jan YN, and Jan LY (2000) Molecular basis for KATP assembly: transmembrane interactions mediate association of a K+ channel with an ABC transporter. Neuron 26: 155-167.[CrossRef][Medline]
Shi NQ, Ye B, and Makielski JC (2005) Function and distribution of the SUR isoforms and splice variants. J Mol Cell Cardiol 39: 51-60.[CrossRef][Medline]
Shindo T, Yamada M, Isomoto S, Horio Y, and Kurachi Y (1998) SUR2 subtype (a and B)-dependent differential activation of the cloned ATP-sensitive K+ channels by pinacidil and nicorandil. Br J Pharmacol 124: 985-991.[CrossRef][Medline]
Shyng S and Nichols CG (1997) Octameric stoichiometry of the KATP channel complex. J Gen Physiol 110: 655-664.
Thomzig A, Laube G, Prüss H, and Veh RW (2005) Pore-forming subunits of KATP channels, Kir6.1 and Kir6.2, display prominent differences in regional and cellular distribution in the rat brain. J Comp Neurol 484: 313-330.[CrossRef][Medline]
Touati G, Poggi-Travert F, Ogier de Baulny H, Rahier J, Brunelle F, Nihoul-Fekete C, Czernichow P, and Saudubray JM (1998) Long-term treatment of persistent hyperinsulinaemic hypoglycaemia of infancy with diazoxide: a retrospective review of 77 cases and analysis of efficacy-predicting criteria. Eur J Pediatr 157: 628-633.[CrossRef][Medline]
Tricarico D, Mele A, Lundquist AL, Desai RR, George AL Jr, and Conte Camerino D (2006) Hybrid assemblies of ATP-sensitive K+ channels determine their muscle-type-dependent biophysical and pharmacological properties. Proc Natl Acad Sci U S A 103: 1118-1123.
Yamada K and Inagaki N (2005) Neuroprotection by KATP channels. J Mol Cell Cardiol 38: 945-949.[CrossRef][Medline]
Yang K, Fang K, Fromondi L, and Chan KW (2005) Low temperature completely rescues the function of two misfolded KATP channel disease-mutants. FEBS Lett 579: 4113-4118.[CrossRef][Medline]
Yokoshiki H, Sunagawa M, Seki T, and Sperelakis N (1999) Antisense oligodeoxynucleotides of sulfonylurea receptors inhibit ATP-sensitive K+ channels in cultured neonatal rat ventricular cells. Pflugers Arch 437: 400-408.[CrossRef][Medline]
Zerangue N, Schwappach B, Jan YN, and Jan LY (1999) A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane KATP channels. Neuron 22: 537-548.[CrossRef][Medline]
Zingman LV, Hodgson DM, Bast PH, Kane GC, Perez-Terzic C, Gumina RJ, Pucar D, Bienengraeber M, Dzeja PP, Miki T, et al. (2002) Kir6.2 is required for adaptation to stress. Proc Natl Acad Sci U S A 99: 13278-13283.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||